Global Cervical Cancer Diagnostics: Forecast to 2022

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022 • By Type - Pap Test, HPV Test, Colposcopy and Cervical Biopsies.

• By Age Group – Below 35 years and 35 years and above.

• By Region- North America, Europe, Asia Pacific, and ROW. • By Country - U.S, Canada, Germany, U.K, China, India, Mexico and Brazil.

January 2018

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022

  gScope of the Study

 Global Coverage

Segment Coverage

 Region (North America, Europe, APAC and ROW)

 Regional Coverage

 By Type

 Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China,

 Country Coverage

 By Age Group

Global Coverage

 Global Cervical Cancer Diagnostics Market – By Value (2012-16)

 Global Cervical Cancer Diagnostics

Regional Coverage

 U.S.

 Europe

 Canada

 Asia Pacific

 Mexico

 ROW

 Brazil  Germany

 Global Cervical Cancer Diagnostics

 U.K

Market Breakdown- By Type, By Value

 HPV Test

Country Coverage

 North America

Market – By Value (2017-22)

 Pap Test

and India)

 Cervical Cancer Diagnostics

 China  India

Company Coverage  Hologic, Inc.  Abott Laboratories  Roche Diagnostics  Guided Therapeutics  Becton, Dickinson and Company  Qiagen  Quest Diagnostics  Arbor Vita Corporation

Market, (2012-2016)

 Colposcopy  Cervical Biopsies  Global Cervical Cancer Diagnostics Market Breakdown-By Age Group, By

 Cervical Cancer Diagnostics  Product Benchmarking Market, (2017-2022)  By Value

Value  Below 35 years  35 years and above

 By Type, By Value  By Age Group, By Value

 Cervical Cancer Diagnostics Market (2012-2022)

 Sales*  Business Overview

 By Value

 Recent Product Approvals

 By Type, By Value

 Merger & Acquisition

 By Age Group, By Value

*for listed companies only.

2

Table of Content S.No

Particulars

Page No.

1.

Research Methodology

20

2.

Executive Summary

21

3.

Strategic Recommendation

22

3.1

Increasing demand for HPV tests in global cervical cancer diagnostics market.

23

3.2

Asia Pacific Region to witness the fastest growth in cervical cancer diagnostics market in the forecast period.

24

4.

Cervical Cancer Outlook

25

5.

Global Cervical Cancer Diagnostics Market: Growth and Forecast

38

6.

5.1

By Value (2012-2016)

39

5.2

By Value (2017-2022)

40

Global Cervical Cancer Diagnostics Market â&#x20AC;&#x201C; Segmental Analysis

47

3

Table of Content S.No

Particulars

6.1

6.2

Global Cervical Cancer Diagnostics Market Size, By Type: Breakdown (%)

Page No.

47

6.1.1

Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)

49

6.1.2

Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)

50

6.1.3

Global Pap Test Market, By Value (2012-2022)

51

6.1.4

Global HPV Test Market, By Value (2012-2022)

52

6.1.5

Global Colposcopy Market, By Value (2012-2022)

53

6.1.6

Global Cervical Biopsies Market, By Value (2012-2022)

54

Global Cervical Cancer Diagnostics Market Size, By Age Group, Breakdown (%)

55

6.2.1

Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)

56

6.2.2

Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)

57

4

Table of Content S.No

7.

Particulars

6.2.3

Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022)

58

6.2.4

Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above),

By Value (2012-2022)

59

Global Cervical Cancer Diagnostics Market: Regional Analysis 7.1

7.2

Page No.

Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%)

60 60

7.1.1

Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)

61

7.1.2

Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)

62

North America Cervical Cancer Diagnostics Market: Growth and Forecast

63

7.2.1

By Value (2012-2016)

64

7.2.2

By Value (2017-2022)

65

7.2.3

By Type, By Value (2012-2022)

71

5

Table of Content S.No

Particulars

7.2.4

7.3

7.4

By Age Group, By Value (2012-2022)

North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada)

Page No.

72

73

7.3.1

U.S Cervical Cancer Diagnostics Market, By Value (2012-2022)

75

7.3.2

U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

77

7.3.3

U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

78

7.3.4

Canada Cervical Cancer Diagnostics Market, By Value (2012-2022)

80

7.3.5

Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

81

7.3.6

Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

82

Europe Cervical Cancer Diagnostics Market: Growth and Forecast 7.4.1

By Value (2012-2016)

85 86

6

Table of Content S.No

Particulars

7.5

7.4.2

By Value (2017-2022)

7.4.3

By Type, By Value (2012-2022)

7.4.4

By Age Group, By Value (2012-2022)

Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K)

Page No.

87

94

95

96

7.5.1

Germany Cervical Cancer Diagnostics Market, By Value (2012-2022)

98

7.5.2

Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

99

7.5.3

Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

100

7.5.4

U.K Cervical Cancer Diagnostics Market, By Value (2012-2022)

102

7.5.5

U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

103

7.5.6

U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

104

7

Table of Content S.No

Particulars

7.6

7.7

APAC Cervical Cancer Diagnostics Market: Growth and Forecast

Page No.

106

7.6.1

By Value (2012-2016)

107

7.6.2

By Value (2017-2022)

108

7.6.3

By Type, By Value (2012-2022)

114

7.6.4

By Age Group, By Value (2012-2022)

115

APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India)

116

7.7.1

China Cervical Cancer Diagnostics Market, By Value (2012-2022)

118

7.7.2

China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

119

7.7.3

China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

120

7.7.4

India Cervical Cancer Diagnostics Market, By Value (2012-2022)

122

8

Table of Content S.No

Particulars

7.8

7.9

Page No.

7.7.5

India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

123

7.7.6

India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

124

ROW Cervical Cancer Diagnostics Market: Growth and Forecast

126

7.8.1

By Value (2012-2016)

127

7.8.2

By Value (2017-2022)

127

7.8.3

By Type, By Value (2012-2022)

129

7.8.4

By Age Group, By Value (2012-2022)

130

ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico)

131

7.9.1

Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022)

133

7.9.2

Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

135

9

Table of Content S.No

8.

9.

Particulars

Page No.

7.9.3

Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

136

7.9.4

Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022)

138

7.9.5

Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)

140

7.9.6

Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)

141

Global Cervical Cancer Diagnostics Market Dynamics

143

8.1

Global Cervical Cancer Diagnostics Market Drivers

144

8.2

Global Cervical Cancer Diagnostics Market Restraints

148

Global Cervical Cancer Diagnostics Market Trends

150

10.

Porter Five Force Analysis

153

11.

SWOT Analysis

155

10

Table of Content S.No

Particulars

Page No.

12.

Supply Chain Analysis

157

13.

Pricing Analysis

159

14.

Competitive Landscape:

164

14.1

Company Share Analysis of Key Industry Players

165

14.2

Product Benchmarking of Key Industry Players

167

14.3

Recent Product Approvals of Key Industry Players

169

15.

Policy and Regulatory Landscape

170

16.

Company Profiling

175

16.1

Hologic

176

16.2

Abott Laboratories

178

11

Table of Content S.No

17.

Particulars

Page No.

16.3

Roche

181

16.4

Guided Therapeutics

183

16.5

Becton, Dickinson and Company

185

16.6

Qiagen

187

16.7

Quest Diagnostics

189

16.8

Arbor Vita Corporation

191

About Us

192

12

List of Figures Figure No.

Figure Title

Page No.

Figure 1:

Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

39

Figure 2:

Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)

40

Figure 3:

Healthcare Costs Per Capita, By Select Countries, 2015 (USD)

41

Figure 4:

World Female Population Estimates, 2017 (In Millions)

43

Figure 5:

Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region

43

Figure 6:

Top 10 Most Frequent Cancer in Females, World, (Ageâ&#x2C6;&#x2019;standardised incidence rate per 100,000 women)

44

Figure 7:

Top 10 Most Frequent Cancer Deaths in Females, World, (Ageâ&#x2C6;&#x2019;standardised incidence rate per 100,000 women)

44

Figure 8:

Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)

49

Figure 9:

Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)

50

Figure 10:

Global PAP Test Market, By Value, 2012-2016 (USD Million)

51

Figure 11:

Global PAP Test Market, By Value, 2012-2016 (USD Million)

51

Figure 12:

Global HPV Test Market, By Value, 2012-2016 (USD Million)

52

Figure 13:

Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million)

52

Figure 14:

Global Colposcopy Test Market, By Value, 2012-2016 (USD Million)

53

Figure 15:

Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million)

53

Figure 16:

Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million)

54

Figure 17:

Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million)

54

Figure 18:

Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)

56

Figure 19:

Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)

57

13

List of Figures Figure No.

Figure Title

Page No.

Figure 20:

Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million)

58

Figure 21:

Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million)

58

Figure 22:

Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million)

59

Figure 23:

Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 20172022 (USD Million)

59

Figure 24:

Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)

61

Figure 25:

Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)

62

Figure 26:

North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

64

Figure 27:

North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)

65

Figure 28:

North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)

66

Figure 29:

North America GDP, 2012-2015 (USD Trillion)

66

Figure 30:

North America GDP, By Select Country, 2016 (USD Trillion)

66

Figure 31:

United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD)

67

Figure 32:

Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD)

67

Figure 33:

United States of America, Female Population in the age group 15-64, 2012-2016

68

Figure 34:

Canada, Female Population in the age group 15-64, 2012-2016

68

Figure 35:

North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

71

Figure 36:

North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

72

Figure 37:

U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

75

Figure 38:

U.S Health Spending, By Service or Product, 2016 (%)

76

Figure 39:

U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

77 14

List of Figures Figure No.

Figure Title

Page No.

Figure 40:

U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

78

Figure 41:

Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

80

Figure 42:

Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

81

Figure 43:

Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

82

Figure 44:

North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)

84

Figure 45:

North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)

84

Figure 46:

North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)

86

Figure 47:

Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)

87

Figure 48:

Europe, GDP, By Select Country, 2016, (USD Billion)

89

Figure 49:

Europe Health Spending Per Capita, By Select Country, 2016 (USD)

89

Figure 50:

United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD)

90

Figure 51:

Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD)

90

Figure 52:

United Kingdom, Female Population in the age group 15-64, 2012-2016

91

Figure 53:

Germany, Female Population in the age group 15-64, 2012-2016

91

Figure 54:

Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%)

92

Figure 55:

Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

94

Figure 56:

Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

95

Figure 57:

Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

98

Figure 58:

Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

99

Figure 59:

Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

100

Figure 60:

U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

102

15

List of Figures Figure No.

Figure Title

Page No.

Figure 61:

U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

103

Figure 62:

U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

104

Figure 63:

Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)

105

Figure 64:

Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)

105

Figure 65:

APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

107

Figure 66:

APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)

108

Figure 67:

APAC, GDP, By Select Country, 2016, (USD Billion)

110

Figure 68:

APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)

110

Figure 69:

China, Female Population in the age group 15-64, 2012-2016

111

Figure 70:

India, Female Population in the age group 15-64, 2012-2016

111

Figure 71:

India, Degree of Urbanization, 2012-2016 (in %)

112

Figure 72:

China, Degree of Urbanization, 2012-2016, (in %)

112

Figure 73:

APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

114

Figure 74:

APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

115

Figure 75:

China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

118

Figure 76:

China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

119

Figure 77:

China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

120

Figure 78:

China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

122

Figure 79:

India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

123

Figure 80:

India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

124

16

List of Figures Figure No.

Figure Title

Page No.

Figure 81:

APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)

125

Figure 82:

APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)

125

Figure 83:

ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

127

Figure 84:

ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

129

Figure 85:

ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

130

Figure 86:

ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

133

Figure 87:

Brazil, Female Population in the age group 15-64, 2012-2016

134

Figure 88:

Brazil, Degree of Urbanization, 2012-2016 (in %)

134

Figure 89:

Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

135

Figure 90:

Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

136

Figure 91:

Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)

138

Figure 92:

Mexico, Female Population in the age group 15-64, 2012-2016

139

Figure 93:

Mexico, Degree of Urbanization, 2012-2016 (in %)

139

Figure 94:

Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

140

Figure 95:

Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

141

Figure 96:

ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)

142

Figure 97:

ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)

142

Figure 98:

Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%)

165

Figure 99:

Hologic, Revenue, 2013-2017 (USD Billion)

177

Figure 100:

Hologic, Revenue, By Geography, 2017 (%)

177

17

List of Figures Figure No.

Figure Title

Page No.

Figure 101:

Hologic, Revenue, By Segment, 2017 (%)

177

Figure 102:

Abbott Laboratories, Revenue, 2012-2016 (USD Million)

179

Figure 103:

Abobott Laboratories, Revenue, By Segment, 2016 (%)

179

Figure 104:

Abbott, Revenue, By Geography, 2016 (%)

180

Figure 105:

Roche, Revenue, 2012-2016 (USD Million)

182

Figure 106:

Roche, Revenue, By Segment, 2016 (%)

182

Figure 107:

Roche, Revenue, By Geography, 2016 (%)

182

Figure 108:

Guided Therapeutics, Sales, 2012-2016 (USD thousands)

184

Figure 109:

BD, Revenue, 2012-2016 (USD Million)

186

Figure 110:

BD, Revenue, By Geography, 2017 (%)

186

Figure 111:

BD, Revenue, By Segment, 2017 (%)

186

Figure 112:

Qiagen, Revenue, 2012-2016 (USD Millions)

188

Figure 113:

Qiagen, Revenue, By Geography, 2016 (%)

188

Figure 114:

Qiagen, Revenue, By Product Categories, 2016 (%)

188

Figure 115:

Quest Diagnostics, Revenue, 2012-2016 (USD Millions)

190

Figure 116:

Quest Diagnostics, Revenue, By Business Segments, 2016 (%)

190

18

List of Tables Table No.

Table Title

Page No.

Table A:

List of Abbreviations

26

Table B:

Cervical Cancer Flowchart

34

Table C:

Cervical Cancer Screening Recommendations

35

Table D:

Cervical Cancer Diagnostics Segmentation Flowchart

37

Table E:

Medical Tourism Market Drivers

42

Table F:

Medical Tourism Index, By Region and Top Destinations

42

Table G:

Recent Company Acquisitions in Cervical Cancer Diagnostics Market

46

Table H:

HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015

69

Table I:

Major Players in cervical cancer diagnostics market in North America

83

Table J:

Europe, Female Population aged 15+, By Region, 2017, (In Millions)

88

Table K:

Major Players in cervical cancer diagnostics market in Europe

92

Table L:

Pricing Analysis of PAP TEST

160

Table M:

Pricing Analysis of HPV TEST

161

Table N:

Pricing Analysis of Colposcopy Test

162

Table O:

Pricing Analysis of Colposcopy Test

163

Table P:

Roche, Growth Strategy

166

Table Q:

Product Benchmarking of Key Industry Players, By Type

167

Table R:

Product Benchmarking of Key Industry Players, By Type

168

Table S:

Product Benchmarking of Key Industry Players, By Type

169

19

Research Methodology For our study on Global Cervical Cancer Diagnostics Market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of the medical equipment and service industry.

Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other applications. Market sizing and growth in the forecast period (2017-2022) is estimated through revenue mapping, growth of new advance equipment and technology and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: Global Cervical Cancer Diagnostics Market.

- By Type (Pap Test, HPV Test, Colposcopy and Cervical Biopsies) - By Age Group ( Below 35 years and 35 years and above) - By Region (North America, Europe, Asia Pacific and ROW),

- By Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China and India) - Company Coverage (Roche, Hologic, Abott Laboratories, Guided Therapeutics, Qiagen, etc.)

Companies Contacted: Qiagen, Recombigen Laboratories

(c) AZOTH Analytics

20

Global Cervical Cancer Diagnostics Market Overview Growing healthcare awareness in addition to increased expenditure in healthcare sector has been boosting the global cervical cancer diagnostics market.

Figure : Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) CAGR 2012-2016 xxxx%

2012

2013

2014

2015

2016

Source: Azoth Analytics Estimates

xxxx Xxxx Xxxx Xxxx xxxx

21

Global Colposcopy Test Market Global Low Temperature Sterilization Market, By Value Figure : Global Colposcopy Test Market, By Value,

Figure : Global Colposcopy Test Market, By Value,

2012-2016 (USD Million)

Forecast, 2017-2022 (USD Million)

2012

2013

CAGR 2012-2016

CAGR 2017-2022

xxxx%

xxxx%

2014

2015

2016

2017

2018

2019

2020

2021

2022

Source: Azoth Analytics Estimates Xxxx Xxxx Xxxx Xxxx xxxx xxxxx 22

Global Cervical Cancer Diagnostics Market- By Age Group Female population aged 35 years and above held the major market share of approximately 74.44% in the year 2016.

Key Drivers Figure : Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) Xxxx xxxx

Below 35 years Xxxx

35 years and above

xxxx

Xxxx Source: Azoth Analytics Estimates

xxxx

23

U.K Cervical Cancer Diagnostics Market, By Type Figure : U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) CAGR 2012-2016 Pap Test : xx% HPV Test : xx% Colposcopy : xx% Cervical Biopsies : xx%

2012

2013

2014 Pap Test 2012

CAGR 2017-2022 Pap Test : xx% HPV Test : xx% Colposcopy : xx% Cervical Biopsies : xx%

2015

2016

2017

HPV Test 2013

2014

2015

2018

Colposcopy 2016

2017

2019

2020

2021

2022

Cervical Biopsies 2018

2019

2020

2021

2022

Pap Test HPV Test Colposcopy Cervical Biopsies Xxxx xxxx

Source: Azoth Analytics Estimates 24

ROW Cervical Cancer Diagnostics Market, By Age Group Figure : ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

2012

CAGR 2012-2016

CAGR 2017-2022

Below 35 years : xx%

Below 35 years : xx%

35 years and above : xx%

35 years and above : xx%

2013

2014

2012

2015

2013

2016 Below 35 years 2014

2015

2017

2016

2017

2018 2019 2020 35 years and above 2018

2019

2020

2021

2021

2022

2022

Below 35 years 35 years and above Xxxx Xxxx xxxx Source: Azoth Analytics Estimates 25

About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).

Related Reports: Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)-(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA)

26